<?xml version='1.0' encoding='utf-8'?>
<document id="24867407"><sentence text="Potential drug interactions in travelers with chronic illnesses: a large retrospective cohort study." /><sentence text="Data regarding the prevalence of potential interactions between travel-related medications (TRM) and chronic medications in use, or medical conditions of travelers to developing countries are limited" /><sentence text="" /><sentence text="A retrospective cohort study of travelers to low income countries" /><sentence text=" We extracted data on demographics, travel destinations, use of chronic medications, drug allergies, and relevant medical conditions" /><sentence text=" The following TRM were evaluated: mefloquine, primaquine, doxycycline, atovaquone/proguanil, fluoroquinolone antibiotics, rifaximin, azithromycin, and acetazolamide"><entity charOffset="35-45" id="DDI-PubMed.24867407.s6.e0" text="mefloquine" /><entity charOffset="47-57" id="DDI-PubMed.24867407.s6.e1" text="primaquine" /><entity charOffset="59-70" id="DDI-PubMed.24867407.s6.e2" text="doxycycline" /><entity charOffset="72-82" id="DDI-PubMed.24867407.s6.e3" text="atovaquone" /><entity charOffset="83-92" id="DDI-PubMed.24867407.s6.e4" text="proguanil" /><entity charOffset="94-109" id="DDI-PubMed.24867407.s6.e5" text="fluoroquinolone" /><entity charOffset="123-132" id="DDI-PubMed.24867407.s6.e6" text="rifaximin" /><entity charOffset="134-146" id="DDI-PubMed.24867407.s6.e7" text="azithromycin" /><entity charOffset="152-165" id="DDI-PubMed.24867407.s6.e8" text="acetazolamide" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e0" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e1" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e2" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e3" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e4" e2="DDI-PubMed.24867407.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e4" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e4" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e4" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e4" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e5" e2="DDI-PubMed.24867407.s6.e5" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e5" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e5" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e5" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e6" e2="DDI-PubMed.24867407.s6.e6" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e6" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e6" e2="DDI-PubMed.24867407.s6.e8" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e7" e2="DDI-PubMed.24867407.s6.e7" /><pair ddi="false" e1="DDI-PubMed.24867407.s6.e7" e2="DDI-PubMed.24867407.s6.e8" /></sentence><sentence text="" /><sentence text="A total of 16,263 travelers were included in the analysis, of whom 3299(20%) suffered from chronic illnesses and 2316(14%) reported chronic medication use" /><sentence text=" A potential drug-drug interaction with TRM was identified in 1047(45%) of travelers using chronic medication" /><sentence text=" Fluoroquinolones and azithromycin were the most commonly implicated TRMs"><entity charOffset="1-17" id="DDI-PubMed.24867407.s10.e0" text="Fluoroquinolones" /><entity charOffset="22-34" id="DDI-PubMed.24867407.s10.e1" text="azithromycin" /><pair ddi="false" e1="DDI-PubMed.24867407.s10.e0" e2="DDI-PubMed.24867407.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24867407.s10.e0" e2="DDI-PubMed.24867407.s10.e1" /></sentence><sentence text=" A potential medical condition interaction with TRM was identified in 717(22%) of travelers having chronic illnesses" /><sentence text=" acetazolamide, primaquine and mefloquine, were the most commonly TRMs implicated"><entity charOffset="1-14" id="DDI-PubMed.24867407.s12.e0" text="acetazolamide" /><entity charOffset="16-26" id="DDI-PubMed.24867407.s12.e1" text="primaquine" /><entity charOffset="31-41" id="DDI-PubMed.24867407.s12.e2" text="mefloquine" /><pair ddi="false" e1="DDI-PubMed.24867407.s12.e0" e2="DDI-PubMed.24867407.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24867407.s12.e0" e2="DDI-PubMed.24867407.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24867407.s12.e0" e2="DDI-PubMed.24867407.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24867407.s12.e1" e2="DDI-PubMed.24867407.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24867407.s12.e1" e2="DDI-PubMed.24867407.s12.e2" /></sentence><sentence text=" Drug allergies, which can pose a relative contraindication for use of acetazolamide, were reported by 1323(8"><entity charOffset="71-84" id="DDI-PubMed.24867407.s13.e0" text="acetazolamide" /></sentence><sentence text="1%) of all travelers" /><sentence text="" /><sentence text="Potential drug-drug and drug-disease interactions involving TRM might occur in a significant proportion of travelers with chronic medical conditions" /><sentence text=" Education of health practitioners regarding such potential drug interactions and caution when in prescribing travel-related medications is warranted" /><sentence text="" /></document>